Skip to main content
Caplight Logo









Bio Protocol

Bio Protocol

Private
ZugCrypto & Web3https://www.bio.xyz/

Last Round

Seed

Sep 17, 2025

Est. Valuation

$214.4M

Total Funding Raised

$7.19M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Bio Protocol is a decentralized science (DeSci) company that provides a blockchain-based platform for funding, developing, and commercializing biotechnology research through community-owned BioDAOs and AI-driven BioAgents.

Sector

Crypto & Web3

Verticals

Biotechnology, DAOs, Tokenization, Drug Discovery, DeFi

Business Model

B2B2C

Customer Profile

Marketplace Commission, Usage-Based SaaS, Revenue Share

AI Layer

Infrastructure

Keywords

decentralized scienceDeSciBioDAOIP-NFTbiotech fundraisingscientific research agentsAI agentstokenized intellectual propertydecentralized autonomous organizationDAObiotech launchpadagent orchestrationon-chain governancecrypto biotechscientific AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bio Protocol Comparables

Compare Bio Protocol with similar companies based on industry and business-model similarity.

Bio Protocol comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Molecule
88%
ValleyDAO
73%
LabDAO
71%

Bio Protocol Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 17, 2025
Token SaleNov 14, 2024
Token SaleNov 14, 2024
StrategicNov 8, 2024
StrategicNov 8, 2024
Token Sale
Aug 1, 2024

Bio Protocol Investors

Notable investors and investment history

Bio Protocol investors
InvestorRounds
MaelstromSeed
ID TheoryToken Sale
Panga CapitalToken Sale, Seed
L1 DigitalToken Sale
PreludeToken Sale
Zee Prime CapitalToken Sale, Seed
Northpond VenturesToken Sale

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors grew 38% MoM, reaching 33K.

  • Feb 11, 2026

    Grew 15% QoQ, from 26 to 30 employees.

Bio Protocol Filings

Explore SEC and related filing metadata, where available.

Bio Protocol filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bio Protocol's valuation, stock price, and market status.

Is Bio Protocol a public or private company?

Bio Protocol is a private company.

What is the current stock price of Bio Protocol?

Bio Protocol is a private company with no public stock price. No recent secondary market data is available.

How much is Bio Protocol worth (valuation)?

Valuation information for Bio Protocol is not publicly available.

Can I buy Bio Protocol stock?

Bio Protocol shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bio Protocol's last funding round?

Bio Protocol's most recent funding round was Seed on September 17, 2025.

Who are the main investors in Bio Protocol?

Key investors in Bio Protocol include Maelstrom.

Will Bio Protocol IPO soon?

No public IPO plans have been announced for Bio Protocol.

How can I track Bio Protocol secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bio Protocol's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersZug
Employee Range30
Year Founded2022
Last FundingSep 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?